Global drug majors slow R&D offshoring to India

New drug discovery and contract research have taken a back seat as global drug majors have slowed down their research and development offshoring to India. The domestic players could only manage......

Indian pharma cos: Discoverers or copy cats?

For years, Indian pharmaceutical companies were renowned - or, depending on your point of view, notorious - for their copycat expertise in generic drugs. But with New Delhi enacting tougher patent......

Glenmark, US co ink $27m deal

Glenmark Pharmaceuticals Inc, has signed a $27 million royalty deal with international healthcare investment fund Paul Capital Partners' Royalty Fund to finance the development of 16 dermatological......

Glenmark, InvaGen ink deal

Glenmark Pharmaceuticals wholly owned US subsidiary, Glenmark Pharmaceuticals, has made a exclusive marketing tie-up with InvaGen for its Fosinopril Sodium oral tablets (Monopril) in the US market.......